title: Engineered thrombin aims to take on heparin.
authors.affiliation: erdmannj@nasw.org
authors.forename: Jeanne
authors.initials: J
authors.lastname: Erdmann
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D004345:Drug Industry; D015951:Factor Xa / Q000378:metabolism; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D009025:Morpholines / Q000494:pharmacology; D015202:Protein Engineering; D000069552:Rivaroxaban; D013876:Thiophenes / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D006493:Heparin; D000069552:Rivaroxaban; D013917:Thrombin; D015951:Factor Xa